Canagliflozin provides greater attainment of both HbA1c and body weight reduction versus sitagliptin in patients with type 2 diabetes
| Image |  |
|---|---|
| Description | scientific article published on 08 July 2016 |
| Author/s |
author: Fernando Javier Lavalle-González |
| Publication date | July 8, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |